CDLX Cardlytics Inc

Price (delayed)

$103.11

Market cap

$3.39B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.38

Enterprise value

$2.97B

Highlights
The company's quick ratio has surged by 169% YoY and by 62% QoQ
The gross profit has decreased by 18% YoY but it has increased by 6% from the previous quarter
CDLX's revenue is down by 12% year-on-year but it is up by 4.1% since the previous quarter
The net income has plunged by 174% YoY and by 21% from the previous quarter
The EPS has dropped by 151% year-on-year and by 17% since the previous quarter

Key stats

What are the main financial stats of CDLX
Market
Shares outstanding
32.88M
Market cap
$3.39B
Enterprise value
$2.97B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.86
Price to sales (P/S)
15.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.25
Earnings
Revenue
$194.61M
EBIT
-$60.41M
EBITDA
-$47.89M
Free cash flow
-$28.73M
Per share
EPS
-$2.38
Free cash flow per share
-$0.98
Book value per share
$26.69
Revenue per share
$6.64
TBVPS
$25.01
Balance sheet
Total assets
$1.02B
Total liabilities
$278.14M
Debt
$190.88M
Equity
$744.89M
Working capital
$610.54M
Liquidity
Debt to equity
0.26
Current ratio
7.63
Quick ratio
7.55
Net debt/EBITDA
8.83
Margins
EBITDA margin
-24.6%
Gross margin
34.3%
Net margin
-34.3%
Operating margin
-33%
Efficiency
Return on assets
-13.2%
Return on equity
-22.6%
Return on invested capital
-33.5%
Return on capital employed
-6.5%
Return on sales
-31%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDLX stock price

How has the Cardlytics stock price performed over time
Intraday
-1.53%
1 week
-6.4%
1 month
11.66%
1 year
37.61%
YTD
-27.78%
QTD
-6.01%

Financial performance

How have Cardlytics's revenue and profit performed over time
Revenue
$194.61M
Gross profit
$66.83M
Operating income
-$64.16M
Net income
-$66.79M
Gross margin
34.3%
Net margin
-34.3%
The operating income has dropped by 182% year-on-year and by 19% since the previous quarter
The net income has plunged by 174% YoY and by 21% from the previous quarter
The gross profit has decreased by 18% YoY but it has increased by 6% from the previous quarter
The net margin has contracted by 15% from the previous quarter

Growth

What is Cardlytics's growth rate over time

Valuation

What is Cardlytics stock price valuation
P/E
N/A
P/B
3.86
P/S
15.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.25
The EPS has dropped by 151% year-on-year and by 17% since the previous quarter
The price to book (P/B) is 72% lower than the last 4 quarters average of 14.1
CDLX's revenue is down by 12% year-on-year but it is up by 4.1% since the previous quarter
The stock's price to sales (P/S) is 10% more than its last 4 quarters average of 14.3

Efficiency

How efficient is Cardlytics business performance
The return on sales has dropped by 179% year-on-year and by 11% since the previous quarter
The ROE rose by 41% QoQ but it fell by 6% YoY
The ROIC has grown by 31% YoY and by 11% from the previous quarter
The company's return on assets rose by 29% QoQ but it fell by 3.9% YoY

Dividends

What is CDLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDLX.

Financial health

How did Cardlytics financials performed over time
The company's quick ratio has surged by 169% YoY and by 62% QoQ
Cardlytics's current ratio has soared by 162% YoY and by 61% from the previous quarter
The debt is 74% less than the equity
Cardlytics's debt to equity has soared by 189% YoY but it has plunged by 78% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.